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MAP4K family kinases act in parallel to MST1/2
to activate LATS1/2 in the Hippo pathway
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The Hippo pathway plays a central role in tissue homoeostasis, and its dysregulation
contributes to tumorigenesis. Core components of the Hippo pathway include a kinase
cascade of MST1/2 and LATS1/2 and the transcription co-activators YAP/TAZ. In response to
stimulation, LATS1/2 phosphorylate and inhibit YAP/TAZ, the main effectors of the Hippo
pathway. Accumulating evidence suggests that MST1/2 are not required for the regulation of
YAP/TAZ. Here we show that deletion of LATS1/2 but not MST1/2 abolishes YAP/TAZ
phosphorylation. We have identified MAP4K family members—Drosophila Happyhour
homologues MAP4K1/2/3 and Misshapen homologues MAP4K4/6/7—as direct
LATS1/2-activating kinases. Combined deletion of MAP4Ks and MST1/2, but neither alone,
suppresses phosphorylation of LATS1/2 and YAP/TAZ in response to a wide range of signals.
Our results demonstrate that MAP4Ks act in parallel to and are partially redundant with
MST1/2 in the regulation of LATS1/2 and YAP/TAZ, and establish MAP4Ks as components of
the expanded Hippo pathway.
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T
issue homoeostasis is maintained through the precise
regulation of cell proliferation, apoptosis and differentia-
tion; dysregulation of any of these processes can result in
aberrant tissue growth and carcinogenesis. The Hippo pathway,
which is conserved from Drosophila to mammals, has been
recognized as a master regulator of cell fate, tissue homoeostasis
and organ size1–5. Recent advances have rapidly expanded the
understanding of the Hippo pathway, leading to the identification
of more than 30 components of this pathway6,7. However, only
five proteins are considered to comprise the core of the Hippo
pathway in Drosophila: Ste20-like kinase Hippo (Hpo) with its
adaptor protein Salvador (Sav), the NDR family kinase Warts
(Wts) with its adaptor Mats, and the transcriptional effector
Yokie (Yki). The Hpo–Sav complex phosphorylates and activates
Wts–Mats, which in turn phosphorylates and inhibits Yki.
Dysregulation of this Hpo/Wts kinase cascade leads to aberrant
activation of Yki and uncontrolled growth in the Drosophila eye
and wing8–14.
The core components of the Hippo pathway in mammals
consist of Mammalian Ste20-like kinases 1/2 (MST1/2, homo-
logues of Hpo) and their adaptor protein Sav family WW
domain-containing protein 1 (SAV1, homologue of Sav), Large
tumour suppressor 1/2 (LATS1/2, homologues of Wts) and their
adaptor proteins MOB1A/1B (homologues of Mats), and the two
Yki homologues Yes-associated protein (YAP) and transcrip-
tional co-activator with PDZ-binding motif (TAZ). The physio-
logical importance of the Hippo pathway in mammals has been
revealed in many different genetically engineered mouse models.
For example, deleting MST1/2 or overexpressing YAP in the liver
leads to hepatomegaly and hepatocellular carcinogenesis in
mice12,15,16. Deleting the core Hippo pathway components in
mice leads to neoplasia in other organs as well3. Furthermore,
mutations in the core and peripheral Hippo pathway components
are associated with a number of human malignancies17.
A variety of signals have been reported to either activate or
inhibit the Hippo kinase cascade. In epithelial cells, apical–basal
polarity regulates activities of Wts/LATS through interactions
between the upstream components and intercellular junction-
associated proteins6; these interactions may also be responsible
for initiating YAP/TAZ phosphorylation and degradation in
response to cell–cell contact18. Recent reports found that serum
deprivation or energy stress activates LATS1/2 and inhibits
YAP/TAZ19–22. Extracellular hormones can modulate LATS1/2
kinase activity via G-protein-coupled receptors to regulate the
Hippo pathway19,23. Changes in Rho-GTPase activities and
cytoskeletal dynamics appear to be the major mediators for
YAP/TAZ regulation by G-protein-coupled receptors, as well as
cell detachment and mechanical forces24–27.
Although the role of MST1/2 in the Hippo pathway has
been firmly established, accumulating evidence indicates that
MST1/2 are not essential for LATS1/2 activation under various
conditions19,23,24,28, suggesting the existence of MST1/2-
independent LATS-kinases. In this study, we screened a human
kinome library by in vitro kinase assay with LATS1 as the
substrate and identified several mitogen-activated protein kinase
kinase kinase kinase (MAP4K) family members, including
Hematopoietic progenitor kinase 1 (HPK1/MAP4K1), Germinal
centre kinase (GCK/MAP4K2), Germinal centre kinase-like
kinase (GLK/MAP4K3), HPK/GCK-like kinase (HGK/MAP4K4),
Misshapen-like kinase 1 (MINK1/MAP4K6) and TRAF2 and
NCK interacting kinase (TNIK/MAP4K7), as potent LATS1/2-
activating kinases. We further demonstrate that MAP4Ks are
physiological regulators of LATS1/2 and YAP/TAZ in response
to a number of upstream signals. Our results indicate that
MAP4Ks are components of the Hippo pathway by directly
phosphorylating and activating the LATS1/2 kinases.
Results
LATS but not MST is essential for YAP/TAZ regulation. To test
the dependency of YAP/TAZ phosphorylation on MST1/2 or
LATS1/2, we generated MST1/2-dKO and LATS1/2-dKO
HEK293A cells using CRISPR (Clustered regularly interspaced
short palindromic repeats)/Cas9 technology29. We obtained
multiple clones for both MST1/2- and LATS1/2-dKO cells as
confirmed by western blotting with LATS- or MST-specific
antibodies. A representative clone of LATS1/2 or MST1/2
deletion is shown in Fig. 1a. The MOB1 Threonine 35 (MOB1-
T35) is an MST1/2 phosphorylation site whereas the YAP Serine
127 (YAP-S127) is a LATS phosphorylation site. The
phosphorylation of MOB1-T35 was absent in MST1/2-dKO and
the YAP-S127 phosphorylation was absent in LATS1/2-dKO cells
(Fig. 1a,b), validating the functional loss of these genes. However,
MST1/2 deletion did not abolish the YAP-S127 phosphorylation
(Fig. 1b), indicating that MST1/2 are not the only kinases that can
activate LAT1/2 and cause YAP/TAZ phosphorylation.
We tested the roles of LATS1/2 and MST1/2 in YAP/TAZ
phosphorylation in response to a variety of signals. High
cell density induced YAP phosphorylation in wild-type (WT)
HEK293A cells, as shown by YAP-S127 phosphorylation and
mobility shift in phos-tag gels (Fig.1b). TAZ contains two
phosphodegrons and its degradation is strongly enhanced by
LATS-dependent phosphorylation. As anticipated, high cell
density reduced TAZ protein levels (Fig. 1b). However, these
effects were abolished in LATS1/2-dKO cells, in which high
cell density failed to induce YAP phosphorylation or reduce TAZ
protein levels. Surprisingly, MST1/2 deletion did not compromise
YAP phosphorylation or TAZ protein reduction. This observa-
tion was confirmed in MST1/2-dKO U2OS cells (Supplementary
Fig. 1a), in which high density-induced YAP phosphorylation was
only slightly reduced (Supplementary Fig. 1b).
We and others have recently observed that energy stress caused
by glucose starvation or 2-deoxyglucose (2-DG, a non-metaboliz-
able glucose analogue that inhibits glucose metabolism) promotes
YAP phosphorylation20–22. We found that 2-DG treatment did
not induce YAP-S127 phosphorylation in the LATS1/2-dKO cells
(Fig. 1c). In contrast, 2-DG-induced YAP phosphorylation was
largely unaffected in MST1/2-dKO cells (Fig. 1c), as indicated by
the YAP/TAZ mobility shift and the YAP-S127 phosphorylation.
Serum deprivation induces YAP/TAZ phosphorylation by
activating LATS1/2 (ref. 19). We found that serum deprivation
failed to induce YAP/TAZ phosphorylation in LATS1/2-dKO
cells, yet it still induced YAP/TAZ phosphorylation in MST1/
2-dKO cells (Fig. 1d). MST1/2-dKO U2OS cells responded
similarly to 2-DG treatment and serum deprivation as the WT
cells (Supplementary Fig. 1c,d). Actin depolymerization by
Latrunculin B (LatB) also activates the Hippo pathway. The
effect of LatB on YAP/TAZ phosphorylation was completely
blocked in the LATS1/2-dKO cells, and significantly reduced but
still present in the MST1/2-dKO cells (Fig. 1e, Supplementary
Fig. 1e). Collectively, our results suggest that LATS1/2
are required for YAP/TAZ phosphorylation induced by all
signals tested. In contrast, MST1/2 are completely or partially
dispensable for YAP/TAZ regulation under these conditions.
MAP4Ks phosphorylate the LATS hydrophobic motif. MST1/2
phosphorylate the hydrophobic motif of LATS1/2 (LATS-HM),
resulting in LATS1/2 activation30. We compared the
phosphorylation status of LATS-HM (LATS1-T1079/LATS2-
T1041) in WT and MST1/2-dKO cells. Unlike MOB1-T35
phosphorylation that was absent in the MST1/2-dKO cells
(Fig. 1a), phosphorylation of LATS-HM was significantly
reduced but still induced by high cell density (Fig. 2a), 2-DG
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(Fig. 2b) and serum deprivation (Fig. 2c). These results implicate
that, besides MST1/2, other kinases can phosphorylate LATS-HM
under these conditions.
Considering the indispensable role of LATS1/2 in YAP/TAZ
regulation, identification of the MST1/2-independent LATS1/2
kinases is crucial for understanding the Hippo pathway signal
transduction. We, therefore, screened the human kinome using
in vitro kinase assays to identify candidates that can directly
phosphorylate the LATS hydrophobic motif. A truncated human
LATS1 (638-1,130) was expressed and purified from Eschericia
coli, and used as a substrate for the in vitro kinase assays. We
screened a human kinome library31 supplemented with kinase
constructs available in our lab (Fig. 2d), which covered 354 of the
518 putative protein kinases in the human kinome32. By this
approach, we identified MST1/2 and six additional kinases that
can efficiently phosphorylate LATS1-HM (Fig. 2e). These include
MAP4K2/4/6, NIMA-related kinase 9 (NEK9), serine/threonine
kinase 32B (STK32B) and eukaryotic elongation factor-2 kinase
(eEF2K). MAP4K2/4/6 displayed kinase activity comparable with
that of MST2 (Fig. 2f). In contrast, MST3, which was thought to
be more evolutionally related to MST1/2, displayed no significant
kinase activities towards LATS.
MAP4K2/4/6 and MST1/2 both belong to the STE20-like
kinase family, and their kinase domains are highly homologous
to one another33 (Supplementary Fig. 2a). Both MAP4K4/6 and
MST1/2 possess coiled-coil structures (Supplementary Fig. 2b),
which are important for facilitating kinase–substrate interactions,
although MAP4K2/4/6 do not contain Sarah domains that are
present in MST1/2. Notably, MAP4K2/4/6 possess a Citron
domain in their C-terminal regions. The Citron domain is known
for binding of Rac and RhoA34, which are crucial regulators of the
Hippo pathway. For these reasons, the MAP4K family kinases
were the most appealing candidates. Among the MAP4K2/4/6,
MAP4K4 and MAP4K6 are closely related. Therefore, we initially
focused our efforts on MAP4K4.
To verify that MAP4K4, but not an associated kinase in the
MAP4K4 immunoprecipitate, was responsible for LATS1-HM
phosphorylation, we generated a MAP4K4 kinase-inactive
mutant (MAP4K4-K54R). This mutation abolished MAP4K4’s
ability to phosphorylate LATS1 and LATS2 (Fig. 2g). We next
tested whether MAP4K4 could phosphorylate MOB1-T35, a
known MST1/2-specific site, and found that it did not have
significant kinase activity towards MOB1-T35 (Supplementary
Fig. 3a). This is consistent with the observation that MOB1
phosphorylation is completely absent in the MST1/2-dKO cells
(Fig. 1a). Furthermore, MAP4K4 physically interacts with both
LATS1 and LATS2 (Supplementary Fig. 3b,c). We confirmed the
interaction by co-immunoprecipitation of endogenous proteins
(Supplementary Fig. 3d). We also compared the kinase activities
of MAP4K2/4/6 and MST2/3 in cells. Expressing MAP4K2/4/6
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Figure 1 | LATS1/2, but not MST1/2, are essential for YAP regulation by various signals (a) Immunoblots showing CRISPR-mediated deletion of LATS1/
2 and MST1/2 in HEK293A cells. The signal of pMOB1-Threonine 35 (T35) is absent in MST1/2 double knockout (dKO) cells but not in LATS1/2-dKO or
wild-type (WT) cells. (b) Contact inhibition induces YAP phosphorylation and TAZ degradation in MST1/2-dKO but not LATS1/2-dKO cells. 1.5 105,
6 105, and 8 105 cells per well were seeded on six-well plates. 24 h later, the cells were collected for immunoblot and phos-tag gel analyses. (c) Energy
stress still induces YAP phosphorylation in MST1/2-dKO. Cells under low confluence (1.5 105 cells per well were seeded onto six-well plates 24 h before
the treatment) were treated with 25mM 2-DG for 30 or 60min. (d) Serum depletion induces YAP phosphorylation and TAZ degradation in MST1/2-dKO
cells. Cells under low confluence were incubated with serum-free culture medium for 30 or 60min. (e) YAP phosphorylation is induced by actin
depolymerization in the absence of MST1/2. Cells were treated with 0.2mgml 1 Latrunculin B (LatB) for 30 or 60min.
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individually induced LATS-HM phosphorylation, while
expressing MST3 did not (Fig. 2h). Furthermore, MAP4K2/4/6
were as potent as, if not more potent than, MST2 in promoting
LATS-HM phosphorylation.
We next tested whether MAP4Ks could directly activate
LATS1/2 kinase by performing a sequential kinase assay of
MAP4K-LATS-YAP in vitro. Both MST2 and MAP4K4 enhanced
LATS2 autophosphorylation, as determined by LATS activation
loop phosphorylation (pLATS-AL), as well as the ability of
LATS2 to phosphorylate YAP (Fig. 3a). Therefore, the in vitro
reconstitution experiments with purified proteins demonstrate
that MAP4K4 can directly activate LATS. Collectively, our data
strongly suggest MAP4K4 as a direct LATS-activating kinase.
MAP4K4 acts through LATS1/2 to induce YAP phosphorylation.
To investigate the role of MAP4K4 in regulating the Hippo
pathway, we co-transfected MAP4K4 and YAP into WT,
LATS1/2-dKO and MST1/2-dKO cells. Ectopic MAP4K4
expression strongly induced YAP/TAZ phosphorylation in a
LATS1/2-dependent but MST1/2-independent manner (Fig. 3b).
Consistently, inducible MAP4K4 overexpression increased
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Figure 2 | In vitro screen identified MAP4Ks as candidate kinases for LATS1/2. (a) LATS1/2 phosphorylation is still induced, though weaker, by high cell
confluence in MST1/2-dKO cells. An antibody targeting the hydrophobic motif of LATS1/2 kinase domain (pLATS-HM) was used for immunoblotting.
(b) Energy stress by 2-DG induces MST1/2-independent LATS1/2 phosphorylation. (c) Serum starvation induces MST1/2-independent LATS1/2
phosphorylation. (d) A scheme of the in vitro human kinome screening for LATS1/2-HM kinases. Flag-tagged individual kinases were expressed and purified
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phosphorylate human LATS1 and mouse LATS2. Wild-type and kinase-dead (KR) MST2 and MAP4K4 proteins purified from HEK293A cells were used for
the kinase assays. (h) Overexpression of MAP4K2/4/6 induces LATS1 phosphorylation at both its hydrophobic motif (HM) and activation loop (AL) in the
HEK293A cells. HA-LATS1 was immunoprecipitated from lysates of the HEK293A cells transfected with the kinase expression plasmids, and then examined
for its phosphorylation.
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phosphorylation of endogenous YAP and LATS, whereas
expression of the MAP4K4 kinase-dead mutant (MAP4K4-KR)
suppressed the phosphorylation of LATS and YAP (Fig. 3c).
Therefore, the MAP4K4-KR likely acted in a dominant-negative
manner. We thus overexpressed the WT and the kinase-dead
MAP4K4 in HEK293A cells, and tested YAP phosphorylation
in response to various signals. As expected, the kinase-
dead MAP4K4-KR, but not WT MAP4K4, antagonized YAP
phosphorylation induced by high cell density, serum deprivation
or LatB treatment (Supplementary Fig. 4), suggesting a role of
MAP4K4 in YAP regulation by different signals.
YAP/TAZ interact with TEA domain family (TEAD) tran-
scription factors to promote gene transcription. Phosphorylation
of YAP leads to its cytoplasmic localization and reduces its
interaction with TEAD. As expected, MAP4K4 overexpression
decreased YAP-TEAD4 association (Fig. 3d). Consistently, the
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Figure 3 | MAP4K4 acts through LATS to phosphorylate and inhibit YAP. (a) A sequential kinase assay demonstrates that MAP4K4 activates LATS2 by
in vitro phosphorylation. The hypophosphorylated and inactive GST-tagged full-length LATS2 purified from the HEK293A cells treated with fresh FBS for
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the reaction to measure GST-LATS2 kinase activity. (b) MAP4K4 overexpression induces YAP phosphorylation in a LATS1/2-dependent manner in
HEK293A cells. (c) Doxycycline (Dox) inducible expression shows that the kinase activity of MAP4K4 is required to increase YAP and LATS
phosphorylation in HEK293A cells. (d) MAP4K4 reduces YAP-TEAD interaction in HEK293A cells. HA-YAP, Myc-TEAD4, and MAP4K4 or MST2
constructs were co-transfected into HEK293A cells. TEAD4 was thereafter immunoprecipitated with anti-Myc antibody followed by immunoblotting with
anti-HA antibody. (e) MAP4K4 suppresses TEAD reporter activity. The constructs expressing the indicated genes were co-transfected with a TEAD firefly
luciferase reporter into HEK293A cells. 3 replicates are included in this experiment. The error bars represent s.d. ***Po0.001; student’s t-test was applied.
(f) MAP4K4 suppresses the expression of YAP target genes CTGF and CYR61. The cells with tetracycline-inducible MAP4K4 overexpression were
incubated with doxycycline for 24 h, and then their CTGF and CYR61 expression were measured by quantitative real-time PCRs. Two replicates are included
in this experiment. The error bars represent s.d. *Po0.05; **Po0.01; Student’s t-test was applied. (g) MAP4K4 inhibits cell growth in a manner dependent
on LATS1/2. WTand LATS1/2-dKO HEK293A cells were transfected with MAP4K4 and its KR mutant constructs. The cell number was counted every 24 h.
3 replicates are included in this experiment. The error bars represent s.e.m. *Po0.05; **Po0.01; MAP4K4-KR versus control. #Po0.05; ##Po0.01;
MAP4K4-WT vs. control. Student’s t-test was applied.
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activity of a TEAD luciferase reporter and the expression of YAP
target genes (Connective tissue growth factor CTGF and
Cysteine-rich angiogenic inducer 61 CYR61) were also signifi-
cantly decreased by MAP4K4 overexpression (Fig. 3e,f). In
contrast, the kinase-dead MAP4K4 promoted the transcription of
CTGF and CYR61. Furthermore, we tested whether MAP4K4
could inhibit cell proliferation through LATS1/2. Overexpression
of MAP4K4, but not the kinase-dead mutant, suppressed the
proliferation of WT cells. Importantly, MAP4K4 did not inhibit
the proliferation of LATS1/2-dKO cells (Fig. 3g). Collectively,
these results suggest a model where MAP4K4 acts through LATS
to inhibit YAP and cell proliferation.
Deletion of MAP4K4/6/7 reduces YAP phosphorylation. To
determine the in vivo functions of MAP4K4, we deleted MAP4K4
by CRISPR in HEK293A cells (Supplementary Fig. 5a,b). How-
ever, deletion of MAP4K4 alone had no obvious effects on YAP
phosphorylation under the conditions tested (Supplementary
Fig. 5c,d,e). We speculated that this lack of effect could be due to
functional redundancy with the kinases related to MAP4K4,
such as MAP4K6 and MAP4K7, which are homologous to the
Drosophila Misshapen (Msn) and also expressed in HEK293A
cells (Supplementary Fig. 2b, Supplementary Fig. 5a)35.
Therefore, we generated HEK293 cell lines with the MAP4K4/
6/7 triple deletion (tKO; Fig. 4a). MAP4K4/6/7 deletion modestly
decreased the basal level of YAP phosphorylation based on
phos-tag gel analysis, although it did not have significant impacts
on density-induced YAP phosphorylation (Fig. 4b). Moreover,
the MAP4K4/6/7-tKO cells showed decreased or delayed
phosphorylation of LATS1/2 and YAP in response to energy
stress and serum deprivation (Fig. 4c,d). LATS phosphorylation
and YAP mobility shift induced by LatB were also slightly
reduced in MAP4K4/6/7-tKO cells (Fig. 4e).
Serum deprivation rapidly induces YAP/TAZ phosphorylation
and cytoplasmic localization in 30min, which was, as expected,
abolished in the LATS1/2-dKO cells (Fig. 4f), confirming the
essential role of LATS1/2 in YAP/TAZ regulation by serum. In
contrast, MST1/2 deletion caused only marginal defect on serum
starvation-induced YAP/TAZ cytoplasmic localization. On the
other hand, MAP4K4/6/7 deletion more significantly suppressed
the serum deprivation-induced YAP/TAZ cytoplasmic localiza-
tion (Fig. 4f,g). However, YAP was still translocated into nucleus
on longer serum starvation. Taken together, our observations
support a physiological role of MAP4K4/6/7 in Hippo pathway
regulation.
MAP4K4/6/7 regulate LATS1/2 in parallel to MST1/2.
Although our results collectively suggest that MAP4K4/6/7 are
involved in LATS-dependent YAP phosphorylation in response
to various signals, the YAP phosphorylation was not completely
abolished in the MAP4K4/6/7-tKO. One possible explanation is
the functional redundancy between MAP4K4/6/7 and MST1/2.
To test this hypothesis, we first deleted MAP4K4 in the MST1/2-
dKO cells (Supplementary Fig. 6a). The MST1/2-MAP4K4-tKO
cells showed a significant defect in YAP phosphorylation in
response to serum deprivation, LatB and high cell density
compared with MST1/2-dKO cells (Supplementary Fig. 6b,c,d).
Notably, significant YAP phosphorylation was still observed in
the MST1/2-MAP4K4-tKO cells. Given the functional redun-
dancy of MAP4K4/6/7 revealed in the Fig. 4a, we then generated
several lines of the MST1/2-MAP4K4/6/7 5KO (MM-5KO) cells
by using different guide RNAs for MAP4K4/6/7 in MST1/2-dKO
cells to minimize off-target effects (Fig. 5a, Supplementary Fig. 7a,
Supplementary Table 1). Deletion of all five kinases severely
blocked basal phosphorylation of LATS and YAP (Fig. 5b).
Consistently, TAZ protein levels were also significantly elevated.
We further found that, though high cell density still induced
LATS and YAP/TAZ phosphorylation in MM-5KO cells, the
levels of LATS and YAP phosphorylation were significantly
lower than the WT cells (Fig. 5b, Supplementary Fig. 7b). The
2-DG-induced phosphorylation of LATS and YAP/TAZ was also
abolished in the MM-5KO cells, similar to that observed in
the LATS1/2-dKO cells (Fig. 5c). Serum deprivation-induced
phosphorylation of LATS and YAP/TAZ was largely blocked in
MM-5KO cells (Fig. 5d, Supplementary Fig 7c). Furthermore, a
minimal induction of LATS and YAP/TAZ phosphorylation was
observed on LatB treatment (Fig. 5e, Supplementary Fig. 7d). To
evaluate the synergistic effects of MST1/2 and MAP4K4/6/7, we
serum-starved cells for a longer time (60min). Consistent with
the YAP phosphorylation, MM-5KO cells showed significantly
reduced YAP cytoplasmic localization in response to serum
deprivation compared with MST1/2-dKO and MAP4K4/6/7-tKO
cells (Fig. 5f,g). The effects on both YAP phosphorylation and
localization by deleting the five kinases were much more dramatic
than deleting either MST1/2 or MAP4K4/6/7 alone, suggesting
that MST1/2 and MAP4K4/6/7 function in a partially redundant
manner to activate LATS1/2 and, therefore, lead to YAP/TAZ
phosphorylation and inactivation.
Phosphorylation of YAP and TAZ by LATS inhibits their
transcriptional activity. We examined the effect of MAP4K4/6/7
on the expression of the YAP/TAZ target genes CTGF and
CYR61. As expected, deletion of LATS1/2 strongly induced the
CTGF and CYR61 expression. Deletion of either MST1/2 or
MAP4K4/6/7 significantly increased the expression of CTGF and
CYR61 (Fig. 6a). Moreover, the combined deletion of MST1/2
and MAP4K4/6/7 further elevated the expression of CTGF and
CYR61, which, however, was still lower than that in the LATS1/2-
dKO cells, indicating that additional LATS-activating kinases
are involved in regulating YAP/TAZ transcriptional activity.
Nevertheless, these data demonstrate that MST1/2 and MAP4K4/
6/7 inhibit YAP/TAZ transcriptional activity in a partially
redundant manner.
MAP4K4/6/7 are key components of the Hippo pathway.
To further characterize the upstream signals mediated by
MAP4K4/6/7 and MST1/2, we examined the relationship between
MAP4K4 and other Hippo pathway components. To this end, we
generated knockout cell lines of SAV1 and NF2 in HEK293A
cells. Deletion of SAV1 compromised MST overexpression-
induced, but not MAP4K4 overexpression-induced, YAP phos-
phorylation (Fig. 6b). We further examined the physical
interaction between MAP4Ks and SAV1. Unlike MST1/2, which
interacted with SAV1, MAP4K2 or MAP4K4 did not interact
with SAV1 (Supplementary Fig. 8, Fig. 6c). On the other hand,
deletion of NF2 not only reduced basal YAP phosphorylation but
also compromised YAP phosphorylation by overexpression of
either MAP4K4 or MST2 (Fig. 6b). This observation is consistent
with a proposed role for NF2 to directly interact with LATS36. We
subsequently tested whether some upstream components of the
Hippo pathway act through MST1/2, MAP4Ks or both. KIBRA
overexpression increased YAP phosphorylation. Interestingly,
deletion of MST1/2, but not MAP4K4/6/7, blocked the effect of
KIBRA on YAP phosphorylation (Fig. 6d), suggesting that KIBRA
functions mainly through MST1/2. TAO kinases (TAOKs) are
reported to directly phosphorylate and activate MST1/2 (refs 37,38).
We found that TAOK1 overexpression still induced YAP
phosphorylation in either MST1/2-dKO or MAP4K4/6/7-tKO,
but not the LATS1/2-dKO cells (Fig. 6e). However, deletion of
both MST1/2 and MAP4K4/6/7 significantly blocked the effects
of TAOK1 (Fig. 6e), suggesting that TAOK1 may also act through
both MAP4K4/6/7 and MST1/2 to activate LATS.
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MAP4K1/2/3 play a role in YAP regulation by cell density. The
phosphorylation of LATS and YAP, although strongly decreased,
is still observed in the MM-5KO cells (Fig. 5), suggesting the
existence of additional LATS-activating kinases. Our initial kinase
screen showed that MAPK4K2 could phosphorylate LATS
(Fig. 2f). Therefore, we tested the other MAPK4K subgroup,
MAP4K1/2/3/5, which are highly homologous to the Drosophila
Happyhour, in LATS phosphorylation (Supplementary Fig. 2a).
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Consistent with the initial in vitro LATS kinase screen, MAP4K2
overexpression induced YAP phosphorylation in a LATS1/2-
dependent but MST1/2-independent manner (Supplementary
Fig. 9a). MAP4K1 and MAP4K3, but not MAP4K5, also showed
weak kinase activity towards LATS in vitro (Supplementary
Fig. 9b). Moreover, expression of MAP4K1/2/3 individually
induced YAP phosphorylation in a manner dependent of
LATS1/2, but independent of MST1/2 and MAP4K4/6/7 (Fig. 7a).
In contrast, MAP4K5 did not increase YAP phosphorylation
(Supplementary Fig. 9c). Consistently, the kinase activities of
MAP4K2/3 were required for their ability to induce YAP
phosphorylation (Fig. 7b). To examine the role of endogenous
MAP4K1/2/3 in the Hippo pathway signal transduction, we
deleted MAP4K1/2/3 in the MST1/2 and MAP4K4/6/7 five gene
knockout (KO) cells (MM-5KO) to generate the knockout lines
with deletion of the eight kinases (combined deletion of MST1/2
and MAP4K1/2/3/4/6/7, MM-8KO), which were confirmed by
sequencing of the genomic DNAs (Supplementary Fig. 9d–f
Supplementary Fig. 10a–c) as the commercial antibodies for
MAP4K1/2/3 were not good enough to detect endogenous
proteins. MAP4K1/2/3 deletion further reduced high density-
induced YAP phosphorylation in two independent MM-8KO
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Figure 6 | MAP4K4/6/7 are components of the Hippo pathway. (a) MAP4Ks restrict expression of YAP/TAZ target genes. Quantitative real-time PCR
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clones when compared with the MM-5KO cells (Fig. 7c,
Supplementary Fig. 10d). However, it is worth noting that
residual YAP phosphorylation was still observed in the MM-8KO
cells, indicating the existence of additional LATS-activating
kinase(s). Together, our data demonstrate that the MAP4K family
kinases are physiological LATS-activating kinases and emphasize
the complexity of the Hippo pathway (Fig. 7d).
Msn regulates Yki in parallel to the Hpo kinase. To examine the
function of MAP4K4/6/7 in YAP/TAZ regulation in vivo, we
tested whether Msn and Hpo regulate Yki in parallel, as only one
homologue of each group of the kinases exists in Drosophila. We
thus generated hpomutant clones throughout wing imaginal discs
and knocked down msn in the posterior compartment using the
hh-Gal4 driver. Yki activity was assayed by examining the
expression of the expanded-lacZ (ex-Z) reporter39 and Cubitus
interruptus expression was used to identify the anterior
compartment (Fig. 8a–f). As previously reported, hpo null
mutant clones, marked by lack of GFP, grew large and
displayed increased ex-Z expression compared with GFP-
positive WT cells (Fig. 8b,f). While knockdown of msn alone
had no observable effect on ex-Z expression, hpo msn double
mutant clones in the posterior compartment displayed a further
increase of ex-Z expression (Fig. 8b,c,e arrowheads) compared
with the single hpo clones in the anterior compartment
(Fig. 8b,c,e asterisks). These data support a model in which
Msn contributes to Yki inactivation in parallel to the Hpo kinase.
Discussion
Although MST1/2 are firmly established as the initiating kinases
of the Hippo kinase cascade in mammals, it has been observed
that MST1/2 are not absolutely required for YAP/TAZ regulation
by a number of upstream signals. For example, RNA interference
(RNAi) knockdown of MST1/2 does not affect LATS or YAP
phosphorylation induced by serum depletion or high cell
confluence23,24. MST1/2-dKO mouse livers showed only slightly
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decreased LATS phosphorylation15, and MST1/2-dKO murine
embryonic fibroblasts displayed significant YAP phosphorylation
under serum deprivation19. In this report, we identified MAP4K
family members, including MAP4K1 (HPK1), MAP4K2 (GCK),
MAP4K3 (GLK), MAP4K4 (HGK), MAP4K6 (MINK1) and
MAP4K7 (TNIK), as important physiological LATS-activating
kinases. Notably, a previous study implicated that some MAP4Ks
inhibit YAP reporter activity, although the mechanism was not
revealed40. Mechanistically, MAP4Ks directly phosphorylate the
LATS-HM motif and activate LATS in vitro. Overexpression or
deletion of MAP4Ks affects the phosphorylation and activity of
LATS and YAP/TAZ. By acting in a LATS-dependent, but MST-
independent manner, MAP4Ks restrict the activity of YAP/TAZ
by promoting their phosphorylation and inhibiting target gene
expression. We show that MAP4Ks act in parallel to and display
partial functional redundancy with MST in LATS and YAP/TAZ
regulation. Furthermore, MAP4Ks, together with MST1/2,
constitute the majority of LATS and YAP/TAZ regulatory
activity in response to many upstream signals (Fig. 7d). It is
north noting that for some upstream signals, such as serum
deprivation, MAP4Ks are more important than MST1/2 in the
regulation of LATS and YAP/TAZ.
The Hippo pathway was named after the Drosophila Hpo gene
(homologue of MST1/2), and the major signal output of the
Hippo pathway is the inhibition of YAP/TAZ. This study,
together with other reports, shows that the central regulatory
molecule of the Hippo pathway in mammals is LATS because it is
essential for YAP/TAZ regulation by virtually all signals tested.
Surprisingly, the Hpo homologue MST1/2 are largely dispensable
for YAP/TAZ regulation. We would like to suggest a broad and
new definition of the ‘Hippo pathway’. Proteins that specifically
influence LATS kinase activity and the functional output of
YAP/TAZ should be considered as Hippo pathway components.
Even though MAP4Ks act independently of MST1/2, we propose
that MAP4Ks are components of the Hippo pathway based on
their direct role in LATS1/2 phosphorylation and activation.
Genetic evidence in Drosophila also supports Hpo-independent
regulation of Wts. Loss of function of the Hpo kinase causes
strong phenotypes in imaginal discs and in enterocytes8–10,14,41–43,
the differentiated intestinal cells, but not in other cells such as the
more progenitor-like intestinal enteroblasts, although loss of Wts
causes strong phenotypes in all of these cell types8,44. In addition,
myristylated Wts can partially bypass Hpo to rescue wing size in
hpo mutants, indicating the existence of another Wts-activating
kinase in Drosophila36. Drosophila has two MAP4K homo-
logues, Msn (corresponding to MAP4K4/6/7) and Happyhour
(corresponding to MAP4K1/2/3/5). Hpo is a master regulator of
Drosophila midgut homoeostasis by controlling intestinal stem cell
proliferation through suppressing Yki-induced Upd1/2/3 synthesis
and secretion from enterocytes41–45. A recent study by Li et al.
showed that Msn is also important for the midgut homoeostasis
through controlling Upd3 secretion from another type of midgut
cells, enteroblasts, by inactivating Yki through Wts independently
of Hpo46. In addition, overexpression of MAP4K4 increased the
phosphorylation of LATS and YAP in mammalian cells. Li et al.
proposed that Msn and Hpo activate Wts in a non-redundant
manner46. However, the molecular basis of LATS activation by
MAP4K4 was not revealed in the previous study. Our results are
consistent with the observations described by Li and colleagues that
MAP4Ks act upstream of LATS. Moreover, our study reveals a
mechanistic insight into LATS activation by MAP4Ks, which
directly phosphorylate the LATS-HM, thereby activating the LATS
kinase. We also observed partially redundant functions of Msn and
Hpo as msn knockdown slightly enhanced the hpo loss of function
phenotype in imaginal disc clones (Fig. 8). Furthermore, we
demonstrate that MST1/2 and MAP4Ks have partially redundant
function in mammalian cells to control LATS and YAP/TAZ
activity.
MAP4Ks and MST1/2 clearly have distinct functions although
both can activate LATS and inhibit YAP/TAZ. First, based on the
analyses of MST1/2-dKO cells, MST1/2 are the major kinases
responsible for phosphorylating MOB-T35 (Fig. 1a), and
GFPex-ZCi GFPex-Zex-Z
Ci ex-Z (spectrum) GFP
a b c
d e f
* * *
Figure 8 | Msn knockdown enhances Yki activity in wing imaginal discs. (a–f) Confocal images of a third instar wing imaginal disc stained for
expanded-lacZ (ex-Z) expression to assay Yki activity and for Cubitus interruptus (Ci) to mark the anterior compartment. This disc contains hpo null
mutant clones, which are marked by lack of GFP expression, and has RNAi driven knockdown of msn induced specifically in the posterior compartment
using the Hh-Gal4 driver. Double mutant hpo, msn clones had increased ex-Z expression (arrowheads) compared to hpo single mutant clones (asterisks).
Picture in e uses a ‘spectrum’ colour lookup table to better show differences in ex-Z expression.
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MAP4K4 appears to be ineffective in phosphorylating MOB1
(Supplementary Fig. 3a). Second, regarding upstream signals,
MAP4K4/6/7 are more important than MST1/2 in serum
deprivation-induced YAP phosphorylation (Fig. 4d,f). In contrast,
MST1/2 appear to play a more prominent role in the
phosphorylation of LATS and YAP induced by LatB (Fig. 1e,
Fig. 4e). Third, the relationship to other Hippo pathway
components is not identical between MST1/2 and MAP4K4/6/7.
For instance, MST1/2 are required for KIBRA-induced YAP
phosphorylation but MAP4K4/6/7 are not. In contrast, both
MST1/2 and MAP4K4/6/7 require NF2 to effectively induce YAP
phosphorylation. Moreover, the relationship with SAV1 is different
in which SAV1 is more important for MST than MAP4Ks to
induce YAP phosphorylation. Consistently, unlike MST1/2,
MAP4K4 does not interact with SAV1. We propose that MST1/2
and MAP4Ks have shared, as well as distinct functions, in relaying
upstream signals to the LATS kinases (Fig. 7d). The Drosophila
experiment with knockdown of Msn in Hpo mutants provides
in vivo data supporting the above model. We further propose that
the relative contribution of MST1/2 and MAP4Ks to the Hippo
pathway is dependent on the nature of upstream signals as well as
cell types.
It should be noted that YAP phosphorylation was largely, but
not completely, abolished in the MST1/2-MAP4K1/2/3/4/6/7-8KO
(MM-8KO), indicating the existence of other LATS-activating
kinases. Serum deprivation-induced YAP phosphorylation was
blocked in the MM-5KO cells while high cell-density-induced
YAP phosphorylation was still present, though much reduced, in
the MM-8KO cells. On the other hand, the 2-DG-induced
phosphorylation of LATS and YAP/TAZ was completely
abolished in the MM-5KO cells. These data suggest that different
LATS-activating kinases may preferentially participate in relaying
different upstream signals. However, it is also apparent that there
is no simple one-to-one linear relationship between upstream
signals and the different subgroups of MSTs/MAP4Ks to LATS
activation. Our kinome screen identified additional kinases that
could phosphorylate LATS directly in vitro. Future studies are
required to elucidate the function of NEK9, STK32B, and EEF2K
in the Hippo pathway. This study uncovers the extraordinary
complexity of the Hippo pathway, as numerous kinases relay
upstream signals to LATS to regulate this pathway. This is not
entirely surprising given the fact that the Hippo pathway
responds to a wide range of signals, ranging from cell contact,
extracellular hormones, intracellular energy status, cytoskeletal
integrity, to mechanotransduction. The large numbers of LATS-
activating kinases may serve to relay different upstream signals
and ensure the proper regulation of this important signalling
pathway, therefore to maintain precise control of cell, tissue, and
organ growth and homoeostasis.
Methods
CRISPR. CRISPR genomic editing technology was used for the deletion of genes of
interest29. The guide RNA sequences were cloned into the plasmids px459
(addgene 48319), a gift from Dr Feng Zhang47. The constructed plasmids were
transfected into HEK293A or U2OS cells. 24 h after transfection, the transfected
cells were enriched by 1 mgml 1 puromycin selection for 3 days and then were
sorted onto 96-well plates with only one cell in each well. The clones were screened
by Western blot with gene-specific antibodies and at least two independent clones
for each gene deletion were used for each experiment described. The details of
guide RNA sequences are provided in Supplementary Table 1.
Kinome screening. The flag-tagged human kinome constructs were transfected
into HEK293A cells individually. The kinases were purified from the transfected
cells by immunoprecipitation with anti-flag antibodies and protein A/G magnetic
beads with a high stringency buffer (50mM Tris-HCl pH 7.5, 150mM NaCl,
50mM NaF, 1% Triton X-100, 0.05% SDS, 0.25% Sodium Deoxycholate, 1mM
EDTA and 1mM EGTA). The beads were subsequently washed with a buffer
containing 50mM Tris-HCl pH 7.5 and 150mM NaCl, and then used for kinase
assays with a truncated form of human LATS1 (amino acids 638–1,130) at 30 C
for 30min. A standard kinase assay buffer (0.5mM ATP, 50mM Tris-HCl pH 7.5,
10mM MgCl2, 2mM MnCl2, 0.1mM EDTA, 2mM DTT, 0.01% Brij 35) was used
for most of the kinases except for CAMK family kinases, for which 1.2 mM
calmodulin and 2.0 mM calcium were supplied. The immunoblot with an antibody
detecting phosphorylated LATS hydrophobic motif was performed to detect
LATS-HM phosphorylation signals. The detailed information of the tested kinases
and the results are shown in Supplementary Figs 11–18.
Sequential kinase assay. Full-length GST-tagged mouse LATS2 proteins were
purified from HEK293A cells treated with 10% fetal bovine serum for 45min. The
LATS2 proteins were purified by glutathione agarose slurry and eluted with
glutathione. The proteins were dialyzed in 50mM Tris-HCl pH 7.5, 150mM NaCl,
and then used in the coupled sequential kinase reactions with MST2 or MAP4K4,
which was immunopurified from transfected HEK293A cells in a mild lysis buffer
(20mM Tris-HCl pH 7.5, 100mM NaCl, 50mM NaF, 2mM EDTA, 1% NP40
substitute). 30min after kinase reaction, recombinant GST-tagged YAP purified
from E coli was added to the reaction as a substrate for LATS2. The second step of
the kinase reaction was also performed at 30 C for 30min.
Drosophila genetics and immunohistochemistry. The genotype of the animal
shown in Fig. 8 was y w hsFlp/Y; ex697 FRT42D ubi-GFP/FRT42D, hpo42–47;
hh-Gal4/msn-RNAi. The msn-RNAi line was the verified TRiP line BSC2879146.
Wandering third instar larvae of this genotype were dissected in cold 1
phosphate-buffered saline (PBS; pH 7.2) and fixed in 4% formaldehyde in 1 PBS
for 50min. Samples were permeabilized in 1 PBT (1 PBSþ 0.3% Triton X-100)
and blocked in 5% normal donkey serum in PBT. Primary antibodies were
incubated overnight at 4 C: mouse anti-b-galactosidase (Promega, 1:2,000) and rat
anti-Cubitus interruptus (DSHB, 1:150). Secondary antibodies were incubated for
3 h at room temperature: donkey anti-mouse Cy3 (Jackson, 1:600) and donkey
anti-rat Cy5 (Jackson, 1:600). Samples were mounted in Vectashield (Vector Labs)
and imaged using an Olympus FV1000. Images were processed using ImageJ, and
figures prepared using Adobe software.
Cell culture. HEK293A and U2OS cells were maintained in DMEM containing
10% fetal bovine serum. For low confluence, 1.5 105 cells per well were seeded
onto six-well plates. For high confluence, 6.0 105 or 8 105 cells were seeded per
well. For all the other treatments, low confluence cells were treated with 2-DG
(25mM), serum deprivation, and LatB (0.2 mgml 1).
For tetracycline-inducible gene expression, pRetroX-Tet-on-advanced and
pRetrox-tight-puro plasmids (Clontech) were used to generate the stable cells
according to the manufacturer’s instructions. 500 ngml 1 Doxycycline was used to
induce the gene expression for 24 h.
Immunoblot. Western blot was performed following standard methods. 7.5%
phos-tag gel was used to resolve the phosphor-YAP proteins. The detailed
information of the antibodies is provided in Supplementary Table 2. Uncropped
blots are shown in Supplementary Fig. 19.
Immunofluorescence. HEK293A cells were sparsely seeded on fibronectin-coated
plates. 24 h later, culture medium was replaced with fresh medium for 90min
before the serum deprivation. An antibody targeting YAP/TAZ (sc-101199, San
Cruz Biotechnology, 1:200 dilution) was used for detection. The results were
quantified in three randomly chosen fields for each sample.
Quantitative real-time PCR. RNAs were purified from the cells with tetracycline-
inducible expression of MAP4K4, and subjected to reverse transcription (iScript,
Bio-Rad) that contains random primers and oligo-dT. The real-time PCR was
performed with the Applied Biosystems 7300 with primers targeting CTGF and
CYR61: CTGF-Forward: 50-CCAATGACAACGCCTCCTG-30 , CTGF-Reverse:
50-TGGTGCAGCCAGAAAGCTC-30 ; CYR61-Forward: 50-AGCCTCGCATCCTA
TACAACC-30 , CYR61-Reverse: 50-TTCTTTCACAAGGCGGCACTC-30 .
References
1. Barry, E. R. & Camargo, F. D. The Hippo superhighway: signaling crossroads
converging on the Hippo/Yap pathway in stem cells and development. Curr.
Opin. Cell Biol. 25, 247–253 (2013).
2. Varelas, X. The Hippo pathway effectors TAZ and YAP in development,
homeostasis and disease. Development 141, 1614–1626 (2014).
3. Yu, F. X., Meng, Z., Plouffe, S. W. & Guan, K. L. Hippo pathway regulation of
gastrointestinal tissues. Annu. Rev. Physiol. 77, 201–227 (2014).
4. Moroishi, T., Hansen, C. G. & Guan, K. L. The emerging roles of YAP and TAZ
in cancer. Nat. Rev. Cancer. 15, 73–79 (2015).
5. Piccolo, S., Dupont, S. & Cordenonsi, M. The biology of YAP/TAZ: hippo
signaling and beyond. Physiol. Rev. 94, 1287–1312 (2014).
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms9357
12 NATURE COMMUNICATIONS | 6:8357 | DOI: 10.1038/ncomms9357 | www.nature.com/naturecommunications
& 2015 Macmillan Publishers Limited. All rights reserved.
6. Yu, F. X. & Guan, K. L. The Hippo pathway: regulators and regulations. Genes
Dev. 27, 355–371 (2013).
7. Johnson, R. & Halder, G. The two faces of Hippo: targeting the Hippo pathway
for regenerative medicine and cancer treatment. Nat. Rev. Drug. Discov. 13,
63–79 (2014).
8. Wu, S., Huang, J., Dong, J. & Pan, D. hippo encodes a Ste-20 family protein
kinase that restricts cell proliferation and promotes apoptosis in conjunction
with salvador and warts. Cell 114, 445–456 (2003).
9. Udan, R. S., Kango-Singh, M., Nolo, R., Tao, C. & Halder, G. Hippo promotes
proliferation arrest and apoptosis in the Salvador/Warts pathway. Nat. Cell
Biol. 5, 914–920 (2003).
10. Pantalacci, S., Tapon, N. & Leopold, P. The Salvador partner Hippo promotes
apoptosis and cell-cycle exit in Drosophila. Nat. Cell Biol. 5, 921–927 (2003).
11. Huang, J., Wu, S., Barrera, J., Matthews, K. & Pan, D. The Hippo signaling
pathway coordinately regulates cell proliferation and apoptosis by inactivating
Yorkie, the Drosophila Homolog of YAP. Cell 122, 421–434 (2005).
12. Dong, J. et al. Elucidation of a universal size-control mechanism in Drosophila
and mammals. Cell 130, 1120–1133 (2007).
13. Pan, D. The hippo signaling pathway in development and cancer. Dev. Cell 19,
491–505 (2010).
14. Harvey, K. F., Pfleger, C. M. & Hariharan, I. K. The Drosophila Mst ortholog,
hippo, restricts growth and cell proliferation and promotes apoptosis. Cell 114,
457–467 (2003).
15. Zhou, D. et al. Mst1 and Mst2 maintain hepatocyte quiescence and suppress
hepatocellular carcinoma development through inactivation of the Yap1
oncogene. Cancer Cell 16, 425–438 (2009).
16. Camargo, F. D. et al. YAP1 increases organ size and expands undifferentiated
progenitor cells. Curr. Biol. 17, 2054–2060 (2007).
17. Harvey, K. F., Zhang, X. & Thomas, D. M. The Hippo pathway and human
cancer. Nat. Rev. Cancer. 13, 246–257 (2013).
18. Gumbiner, B. M. & Kim, N. G. The Hippo-YAP signaling pathway and contact
inhibition of growth. J. Cell Sci. 127, 709–717 (2014).
19. Yu, F. X. et al. Regulation of the Hippo-YAP pathway by G-protein-coupled
receptor signaling. Cell 150, 780–791 (2012).
20. DeRan, M. et al. Energy stress regulates hippo-YAP signaling involving
AMPK-mediated regulation of angiomotin-like 1 protein. Cell Rep. 9, 495–503
(2014).
21. Mo, J. S. et al. Cellular energy stress induces AMPK-mediated regulation of
YAP and the Hippo pathway. Nat. Cell Biol. 17, 500–510 (2015).
22. Wang, W. et al. AMPK modulates Hippo pathway activity to regulate energy
homeostasis. Nat. Cell Biol. 17, 490–499 (2015).
23. Yu, F. X. et al. Protein kinase A activates the Hippo pathway to modulate cell
proliferation and differentiation. Genes Dev. 27, 1223–1232 (2013).
24. Zhao, B. et al. Cell detachment activates the Hippo pathway via cytoskeleton
reorganization to induce anoikis. Genes Dev. 26, 54–68 (2012).
25. Dupont, S. et al. Role of YAP/TAZ in mechanotransduction. Nature 474,
179–183 (2011).
26. Halder, G., Dupont, S. & Piccolo, S. Transduction of mechanical and
cytoskeletal cues by YAP and TAZ. Nat. Rev. Mol. Cell Biol. 13, 591–600
(2012).
27. Aragona, M. et al. A mechanical checkpoint controls multicellular growth
through YAP/TAZ regulation by actin-processing factors. Cell 154, 1047–1059
(2013).
28. Kim, N. G., Koh, E., Chen, X. & Gumbiner, B. M. E-cadherin mediates contact
inhibition of proliferation through Hippo signaling-pathway components. Proc.
Natl Acad. Sci. USA 108, 11930–11935 (2011).
29. Cong, L. et al. Multiplex genome engineering using CRISPR/Cas systems.
Science 339, 819–823 (2013).
30. Chan, E. H. et al. The Ste20-like kinase Mst2 activates the human large tumor
suppressor kinase Lats1. Oncogene 24, 2076–2086 (2005).
31. Taipale, M. et al. Quantitative analysis of HSP90-client interactions reveals
principles of substrate recognition. Cell 150, 987–1001 (2012).
32. Manning, G., Whyte, D. B., Martinez, R., Hunter, T. & Sudarsanam, S. The
protein kinase complement of the human genome. Science 298, 1912–1934
(2002).
33. Dan, I., Watanabe, N. M. & Kusumi, A. The Ste20 group kinases as regulators
of MAP kinase cascades. Trends. Cell Biol. 11, 220–230 (2001).
34. Madaule, P. et al. A novel partner for the GTP-bound forms of rho and rac.
FEBS Lett. 377, 243–248 (1995).
35. Sultan, M. et al. A global view of gene activity and alternative splicing by deep
sequencing of the human transcriptome. Science 321, 956–960 (2008).
36. Yin, F. et al. Spatial organization of Hippo signaling at the plasma membrane
mediated by the tumor suppressor Merlin/NF2. Cell 154, 1342–1355 (2013).
37. Boggiano, J. C., Vanderzalm, P. J. & Fehon, R. G. Tao-1 phosphorylates
Hippo/MST kinases to regulate the Hippo-Salvador-Warts tumor suppressor
pathway. Dev. Cell 21, 888–895 (2011).
38. Poon, C. L., Lin, J. I., Zhang, X. & Harvey, K. F. The sterile 20-like kinase Tao-1
controls tissue growth by regulating the Salvador-Warts-Hippo pathway. Dev.
Cell 21, 896–906 (2011).
39. Hamaratoglu, F. et al. The tumour-suppressor genes NF2/Merlin and Expanded
act through Hippo signalling to regulate cell proliferation and apoptosis. Nat.
Cell Biol. 8, 27–36 (2006).
40. Mohseni, M. et al. A genetic screen identifies an LKB1-MARK signalling axis
controlling the Hippo-YAP pathway. Nat. Cell Biol. 16, 108–117 (2014).
41. Karpowicz, P., Perez, J. & Perrimon, N. The Hippo tumor suppressor
pathway regulates intestinal stem cell regeneration. Development 137,
4135–4145 (2010).
42. Shaw, R. L. et al. The Hippo pathway regulates intestinal stem cell proliferation
during Drosophila adult midgut regeneration. Development 137, 4147–4158
(2010).
43. Ren, F. et al. Hippo signaling regulates Drosophila intestine stem cell
proliferation through multiple pathways. Proc. Natl Acad. Sci. USA 107,
21064–21069 (2010).
44. Staley, B. K. & Irvine, K. D. Warts and Yorkie mediate intestinal regeneration
by influencing stem cell proliferation. Curr. Biol. 20, 1580–1587 (2010).
45. Poernbacher, I., Baumgartner, R., Marada, S. K., Edwards, K. & Stocker, H.
Drosophila Pez acts in Hippo signaling to restrict intestinal stem cell
proliferation. Curr. Biol. 22, 389–396 (2012).
46. Li, Q. et al. The conserved misshapen-warts-Yorkie pathway acts in
enteroblasts to regulate intestinal stem cells in Drosophila. Dev. Cell 31,
291–304 (2014).
47. Ran, F. A. et al. Genome engineering using the CRISPR-Cas9 system. Nat.
Protoc. 8, 2281–2308 (2013).
Acknowledgements
This work was supported by grants from the National Institutes of Health (CA132809,
EY022611, DEO15964, CA23100 and CA196878, K.-L.G.). T.M. is supported by the
Japan Society for the Promotion of Science (JSPS) Postdoctoral Fellowships for Research
Abroad and by a grant from the Yasuda Medical Foundation. C.G.H. is supported by a
Postdoctoral Fellowship from the Danish Council for Independent Research | Nature
Sciences. S.W.P. and A.W.H. were supported in part by a University of California, San
Diego (UCSD) Graduate Training Programme in Cellular and Molecular Pharmacology
training grant (T32 GM007752).
Author contributions
Z.M. and K.-L.G designed the research, analysed the data, and wrote the manuscript;
Z.M. performed the experiments with the assistance from T.M., S.W.P, C.G.H, A.H.,
H.W.P., J.-S.M., W.L., S.L., F.F.; F.-X. Y and G.H. provided technical and intellectual
support; V.M.-P. and G.H. designed and performed the Drosophila experiments. All
authors discussed the results and commented on the manuscript.
Additional information
Supplementary Information accompanies this paper at http://www.nature.com/
naturecommunications
Competing financial interests: The authors declare no competing financial interests.
Reprints and permission information is available online at http://npg.nature.com/
reprintsandpermissions/
How to cite this article: Meng, Z. et al. MAP4K Family kinases act in parallel to
MST1/2 to activate LATS1/2 in the Hippo pathway. Nat. Commun. 6:8357
doi: 10.1038/ncomms9357 (2015).
This work is licensed under a Creative Commons Attribution 4.0
International License. The images or other third party material in this
article are included in the article’s Creative Commons license, unless indicated otherwise
in the credit line; if the material is not included under the Creative Commons license,
users will need to obtain permission from the license holder to reproduce the material.
To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms9357 ARTICLE
NATURE COMMUNICATIONS | 6:8357 | DOI: 10.1038/ncomms9357 |www.nature.com/naturecommunications 13
& 2015 Macmillan Publishers Limited. All rights reserved.
